Dachaigh › Ailse sgamhain cealla bheag › Washington › Seattle
Sgrùdaidhean clionaigeach Ailse sgamhain cealla bheag ann an Seattle, WA
Tha 10 sgrùdaidhean airson Ailse sgamhain cealla bheag a’ lorg phàirtichean aig làraichean ann agus timcheall air Seattle (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
A’ fastadhÌre 1
- Fred Hutchinson Cancer Research Center, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- University of Washington Fred Hutchinson, Seattle
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
A’ fastadhÌre 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
A’ fastadhÌre 3
- Swedish Medical Center, Seattle
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
A’ fastadhÌre 1/2
- Avenzo Therapeutics Recruiting Site, Seattle
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
A’ fastadhÌre 1/2
- Fred Hutch Cancer Research, Seattle
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
A’ fastadhÌre 1/2
- Fred Hutch Cancer Center, Seattle
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
A’ fastadhÌre 1/2
- Swedish Cancer Institute, Seattle
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
A’ fastadhÌre 1
- Swedish Cancer Institute, Seattle
Sgrùdaidhean Ailse sgamhain cealla bheag ann am bailtean eile
- Houston, TX26 sgrùdaidhean
- Arlington, VA23 sgrùdaidhean
- Boston, MA21 sgrùdaidhean
- New York City, NY21 sgrùdaidhean
- Nashville, TN20 sgrùdaidhean
- Los Angeles, CA20 sgrùdaidhean
- Orlando, FL15 sgrùdaidhean
- Dallas, TX13 sgrùdaidhean
- St. Louis, MO13 sgrùdaidhean
- Cleveland, OH13 sgrùdaidhean
- Detroit, MI12 sgrùdaidhean
- Washington, DC12 sgrùdaidhean
Sgrùdaidhean eile ann an Seattle
- Aillse Sgamhain Neo-chealla-beag53 sgrùdaidhean
- Aillse (gach seòrsa)49 sgrùdaidhean
- Aillse Prostata42 sgrùdaidhean
- Leukemia myeloid geur40 sgrùdaidhean
- Aillse a' bhroilleach39 sgrùdaidhean
- Ailse metastatach39 sgrùdaidhean
- Aillse colorectal34 sgrùdaidhean
- Ailseachadh nan Sgamhan33 sgrùdaidhean
- Cancer Ovarian30 sgrùdaidhean
- Myeloma iomaill22 sgrùdaidhean
- Siondròman Myelodysplastic21 sgrùdaidhean
- Leukemia lymphoblastic geur21 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.